RÉCONFORTIN PLUS
Natural health product licensed in Canada
- Licence holder
- 9248-8014 Québec Inc.
- NPN or DIN-HM
- 80047552
- Status
- Active licence
- Licence date
- 14 January 2014
- Revision date
- Not provided
- Form
- Comprimé, désagrégeant oralement
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Eucalyptus globulus Source : Feuille | 3 mg | Not calculated |
| Abies balsamea Source : Oléorésine | 2 mg | Not calculated |
Non-medicinal ingredients
Gel de silice colloïdal, Glucose, Maltodextrine, Stéarate de magnésium, Sorbitol, D-Fructose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 14 years | 1 Comprimé | minimum: 3 days ; maximum: 6 days |
Uses authorised in Canada
Aide à soulager les voies respiratoires. Aide à soulager la congestion nasale (catarrhes).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien en soins de santé si les symptômes s'aggravent ou persistent pour plus de 2 jours ou sont accompagnés de fortes fièvre. Consulter un praticien en soins de santé avant d'en faire usage si vous êtes enceint ou allaitez.
Source
Official Health Canada record, licence 80047552
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.